Head-to-head · Cost-Efficiency Index
Luci vs Mochi Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Luci
Patients willing to commit to and prepay a full 12-month plan for the lowest advertised rate.
Visit LuciMochi Health
Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.
Visit Mochi HealthThe verdict
Luci and Mochi Health tie on the Cost-Efficiency Index at 56/100, so neither wins outright on the numbers. For most shoppers we'd start with Luci (ranked #326, a hair above #330) — Patients willing to commit to and prepay a full 12-month plan for the lowest advertised rate. But Mochi Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Luci.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Luci | Mochi Health |
|---|---|---|
| Cost-Efficiency Index | 56/100 | 56/100 |
| Semaglutide / mo | $99/mo (starting dose, 12-month plan, compounded) | $178/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide / mo | $145/mo (starting dose, 12-month plan, compounded) | $278/mo (starting dose, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,136 |
| Tirzepatide / yr (modeled) | $1,740 | $3,336 |
| Coverage | Coverage not published | 15 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #326 | #330 |
Luci
56/100Where the value is
- Offers both semaglutide and tirzepatide
- Named clinical/telehealth partner (DrTelx) rather than zero disclosure
- Clear brand positioning (women-focused weight loss)
The tradeoffs
- Headline 'as low as' prices are explicitly 12-month-prepay-only, with true monthly cost never disclosed
- States-served list is incomplete ('CA, FL, and others')
Mochi Health
56/100Where the value is
- Names five board-certified obesity-medicine physicians on its About page (Valledor, Jones, Barrick, A. Patel, Am. Patel MDs/DOs), unusual specificity for this tier of provider
- Available in all 50 states per the About page, a real expansion from the network dataset's outdated '15 states'
- Membership includes ongoing care-team messaging and coaching, not just a one-time prescription
The tradeoffs
- The advertised '$99' and '$199' medication prices are NOT the monthly cost — a separate $79/mo membership is mandatory and stacks on top, so the real floor is $178/mo (semaglutide) and $278/mo (tirzepatide)
- No compounding pharmacy is named anywhere on the site, including a dedicated /pharmacy page that markets the partnership program without ever identifying a partner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.